KANORICHEM NSE filing

Kanoria Chemicals Q1 FY27 Results: Profit Up, Revenue Grows Across Segments

The RealCase readMedium impact Positive

Kanoria Chemicals & Industries Limited reported its Q1 FY27 results on August 11, 2026. Standalone profit after tax was ₹2,637 lakhs, with EPS at ₹6.03. Consolidated profit after tax was ₹2,636 lakhs. Revenue from operations stood at ₹42,999 lakhs (standalone) and ₹46,037 lakhs (consolidated). The company recognized a gain from the fair valuation of preference shares.

Why it matters

The announcement provides unaudited financial results for the quarter, which are material information for investors. The growth in revenue and profit across segments indicates a positive business performance.

The market read

The company reported positive financial results with increased revenue and profit for the quarter compared to the previous year. The fair valuation of preference shares also contributed positively.

Kanoria Chemicals & Industries Limited announced its unaudited financial results for the quarter ended June 30, 2026, on August 11, 2026. The Board of Directors approved the standalone and consolidated financial results, along with the limited review reports.

For the quarter ended June 30, 2026, the company reported total income of ₹43,901 lakhs on a standalone basis and ₹46,712 lakhs on a consolidated basis. Standalone profit before tax stood at ₹3,525 lakhs, while consolidated profit before tax was ₹3,524 lakhs. The standalone net profit for the quarter was ₹2,637 lakhs, with earnings per share at ₹6.03. On a consolidated basis, the net profit was ₹2,636 lakhs, with earnings per share for continuing operations at ₹6.03.

The company's operations are primarily in the Chemicals segment. Standalone revenue from operations was ₹42,999 lakhs, and consolidated revenue from operations was ₹46,037 lakhs. The Chemicals segment reported standalone results of ₹3,997 lakhs and consolidated results of ₹4,256 lakhs before finance costs and taxes. The Textile segment contributed ₹3,038 lakhs in consolidated revenue.

Key financial events during the quarter include the fair valuation of 4,95,000 Non-Convertible, Non-Cumulative, Non-Participating, Redeemable 7% Preference Shares (NCRPS) of ₹1,000 each, aggregating to ₹4,950 lakhs, issued on April 1, 2026. This resulted in a gain of ₹630 lakhs included in Other Income and a notional interest of ₹8 lakhs in Finance Costs for the quarter.

An exceptional item of ₹1,064 lakhs was recognized in the quarter ended June 30, 2025, and the year ended March 31, 2026, representing impairment in the value of the company's investment in equity shares of APAG Holding AG. For the consolidated results, the loss of control of APAG Holding AG resulted in an accounting gain of ₹9,766 lakhs for the year ended March 31, 2026, with its operations recognized as discontinued.

Filing to action

What to do with a filing like this

Kanoria Chemicals & Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Kanoria Chemicals & Industries Limited. Read the original for the full detail.

View original filing